Back

Comparative clinical outcomes of carvedilol versus bisoprolol in STEMI survivors after primary PCI: a propensity-score matched analysis

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Contemporary beta‑blocker pharmacotherapy Beta-Blockers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Ji Young Park

Eulji University Hospital, Deajeon (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail
Metoprolol versus bisoprolol in patients with acute myocardial infarction: a target trial emulation study
Doctor T. Yang (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
β-blocker adherence trajectories and 5-year clinical outcomes in PCI-treated ACS patients with LVEF ≥50%: a group-based trajectory modeling analysis
Professor M. Qiu (Shenyang, CN)
Abstract Slides Video
Presentation thumbnail
In-hospital beta-blocker initiation is associated with improved survival in AF-HFpEF with tachycardia
Doctor S. Naito (JP)
Abstract Slides Video
Presentation thumbnail
Beta-blocker therapy after myocardial infarction in the PCI Era: an updated meta-analysis
Doctor J. Aleman (Cebu City, PH)
Abstract Slides Video
Presentation thumbnail
The range of left ventricular ejection fraction associated with survival benefit from beta-blockers
Professor J. Choi (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Contemporary beta‑blocker pharmacotherapy

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of Carvedilol versus Bisoprolol on long-term clinical outcomes in STEMI patients with mid-range LVEF
1 September 2025
thumbnail
Congress Presentation
Clinical outcomes of patients undergoing percutaneous coronary intervention and transcatheter aortic valve implantation versus coronary artery bypass grafting and surgical aortic valve replacement
1 September 2025
thumbnail
Congress Presentation
Impact of morphine use on mortality in STEMI patients treated with primary PCI - preliminary data from a new registry
15 April 2021
thumbnail
Congress Presentation
Reduction of cardiovascular events in patients with cardiovascular disease with the CV-polypill: a retrospective and propensity score matching study
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources